Literature DB >> 29443066

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection.

Eric K Hubner1, Christian Lechler2, Thomas N Rösner2, Birgit Kohnke-Ertel2, Roland M Schmid2, Ursula Ehmer3.   

Abstract

In research models of liver cancer, regeneration, inflammation, and fibrosis, flexible systems for in vivo gene expression and silencing are highly useful. Hydrodynamic tail vein injection of transposon-based constructs is an efficient method for genetic manipulation of hepatocytes in adult mice. In addition to constitutive transgene expression, this system can be used for more advanced applications, such as shRNA-mediated gene knock-down, implication of the CRISPR/Cas9 system to induce gene mutations, or inducible systems. Here, the combination of constitutive CreER expression together with inducible expression of a transgene or miR-shRNA of choice is presented as an example of this technique. We cover the multi-step procedure starting from the preparation of sleeping beauty-transposon constructs, to the injection and treatment of mice, and the preparation of liver tissue for analysis by immunostaining. The system presented is a reliable and efficient approach to achieve complex genetic manipulations in hepatocytes. It is specifically useful in combination with Cre/loxP-based mouse strains and can be applied to a variety of models in the research of liver disease.

Entities:  

Mesh:

Year:  2018        PMID: 29443066      PMCID: PMC5912325          DOI: 10.3791/56613

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  44 in total

1.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

Authors:  G Zhang; V Budker; J A Wolff
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

Review 2.  Latest development in viral vectors for gene therapy.

Authors:  Kenneth Lundstrom
Journal:  Trends Biotechnol       Date:  2003-03       Impact factor: 19.536

3.  A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression.

Authors:  Kum-Joo Shin; Estelle A Wall; Joelle R Zavzavadjian; Leah A Santat; Jamie Liu; Jong-Ik Hwang; Robert Rebres; Tamara Roach; William Seaman; Melvin I Simon; Iain D C Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

4.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

Authors:  F Liu; Y Song; D Liu
Journal:  Gene Ther       Date:  1999-07       Impact factor: 5.250

5.  Gateway(®) recombinational cloning: a biological operating system.

Authors:  Federico Katzen
Journal:  Expert Opin Drug Discov       Date:  2007-04       Impact factor: 6.098

6.  Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.

Authors:  Martin A Hausl; Wenli Zhang; Nadine Müther; Christina Rauschhuber; Helen G Franck; Elizabeth P Merricks; Timothy C Nichols; Mark A Kay; Anja Ehrhardt
Journal:  Mol Ther       Date:  2010-08-17       Impact factor: 11.454

7.  Organ size control is dominant over Rb family inactivation to restrict proliferation in vivo.

Authors:  Ursula Ehmer; Anne-Flore Zmoos; Raymond K Auerbach; Dedeepya Vaka; Atul J Butte; Mark A Kay; Julien Sage
Journal:  Cell Rep       Date:  2014-07-10       Impact factor: 9.423

Review 8.  Maximizing mouse cancer models.

Authors:  Kristopher K Frese; David A Tuveson
Journal:  Nat Rev Cancer       Date:  2007-09       Impact factor: 60.716

9.  Comparison of doxycycline delivery methods for Tet-inducible gene expression in a subcutaneous xenograft model.

Authors:  Christopher Cawthorne; Ric Swindell; Ian J Stratford; Caroline Dive; Arkadiusz Welman
Journal:  J Biomol Tech       Date:  2007-04

10.  Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state.

Authors:  Fulvio Santacatterina; Laura Sánchez-Cenizo; Laura Formentini; Maysa A Mobasher; Estela Casas; Carlos B Rueda; Inmaculada Martínez-Reyes; Cristina Núñez de Arenas; Javier García-Bermúdez; Juan M Zapata; María Sánchez-Aragó; Jorgina Satrústegui; Ángela M Valverde; José M Cuezva
Journal:  Oncotarget       Date:  2016-01-05
View more
  2 in total

1.  Chemoresistance-Associated Silencing of miR-4454 Promotes Colorectal Cancer Aggression through the GNL3L and NF-κB Pathway.

Authors:  Thetchinamoorthy Kannathasan; Wei-Wen Kuo; Ming-Cheng Chen; Vijaya Padma Viswanadha; Chia-Yao Shen; Chuan-Chou Tu; Yu-Lan Yeh; Mahalakshmi Bharath; Marthandam Asokan Shibu; Chih-Yang Huang
Journal:  Cancers (Basel)       Date:  2020-05-14       Impact factor: 6.639

2.  Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing.

Authors:  Nozomi Hanzawa; Koshi Hashimoto; Xunmei Yuan; Kenichi Kawahori; Kazutaka Tsujimoto; Miho Hamaguchi; Toshiya Tanaka; Yuya Nagaoka; Hiroshi Nishina; Sumiyo Morita; Izuho Hatada; Tetsuya Yamada; Yoshihiro Ogawa
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.